CTT Pharmaceutical Holdings, Inc., formerly Mindesta Inc., is a development-stage company. The Company is focused on developing an oral delivery system of medication contained on a disposable film. Its principal asset is an orally administered wafer (the Wafer). The wafer is an orally administrable paper-thin polymer films used as carriers for pharmaceutical agents. The wafer is formed by mixing the film-forming agent with an aqueous solution to form a gel and exposing the gel to a plurality of heating and cooling cycles. The Wafer rapidly dissolves to release the pharmaceutical agent as soon as it comes in contact with saliva, thus obviating the need for water during administration. Its orally administered wafer comprises at least one physiologically acceptable film forming agent and an aqueous solvent characterized by a dissolution rate of at least about 2 milligrams/second (mg/s) in an aqueous environment.